REDUCE

Management of recurrent venous thromboembolism during anticoagulant treatment in cancer patients - a prospective cohort study

Sponsors:

Amsterdam University Medical Center

Amsterdam, the Netherlands

Design

Multinational, prospective, observational cohort study to evaluate clinical outcomes during guideline-recommended LMWH dose escalation for recurrent VTE during LMWH or DOAC treatment for recurrent cancer-associated thrombosis

Participating Sites

Lead Network:

DTN

Countries:

Italy, The Netherlands,

Lead Investigators

Dr. Floris T.M. Bosch, MD